Hainan

300630.SZ

Tags: CN Healthcare Drug Manufacturers - Specialty & Generic

Hainan Poly Pharm. Co., Ltd Price (300630.SZ)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

452,225,608

(3.2364)%

Market Cap of Hainan (300630.SZ)

Market cap:

As of , 300630.SZ has a market cap of . This makes 300630.SZ the 3815th most valuable company in the CN by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Hainan Poly Pharm. Co., Ltd. researches and develops, produces, and sells pharmaceutical products in China. The company offers APIs. The company offers formulations in various therapeutic areas, which include anti-allergy, non-steroid anti-inflammatory, antibiotic, and digestive drugs. Its products include desloratadine preparations in anti-allergy drugs, diclofenac preparations in non-steroidal anti-inflammatory drugs, azithromycin for injection and clarithromycin preparations in antibiotic drugs, and trimebutine maleate preparations in digestive drugs.... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $2.05-20.65
Market Cap 1.38B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

ceo: Ms. Min Hua Fan
IPO Date: March, 29, 2017
Country: CN
Currency: CNY
Headquaters: No Data
Employees: 1565

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: